Shares & Derivatives
TRUMP’S WAR ON OPIOIDS: EFFECT OF SINGAPORE’S HEALTHCARE STOCKS
By Singapore Stocks Investing (SSI)  •  October 29, 2017
  Dear readers, in case you are not aware, in the United States of America, pharmaceutical stocks are currently getting a beating as a result of President Trump’s war on opioids. In case you do not know, opioids are ingredients in certain medications to relieve certain medical symptoms. Though these are prescribed as drugs, the case of abuse like overdose are a cause of concerns in America in light that precious lives have been affected by the abuse of opioids. While US pharmaceutical stocks have sank, medical stocks in Singapore remain rather unfazed based on their stock price performance on 27 Oct 2017. a) Raffles Medical Group stock price remained unchanged b) Singapore Medical Group stock price remained unchanged c) Healthway Medical Group stock price remained unchanged Of course, the above healthcare stocks are not pharmaceutical stocks per se but if there is a lesson which Trump’s war on ......
Read the full article
By Singapore Stocks Investing (SSI)
LEAVE A COMMENT
LEAVE A COMMENT

Your email address will not be published.

*

Your Email Address will not be published
*

Read More Articles
More from thefinance